Tumor Biology

, Volume 35, Issue 1, pp 425–432 | Cite as

Association between the Thr241Met polymorphism of X-ray repair cross-complementing group 3 gene and glioma risk: evidence from a meta-analysis based on 4,136 cases and 5,233 controls

Research Article

Abstract

Genetic polymorphism of X-ray repair cross-complementing group 3 (XRCC3) Thr241Met has been implicated to alter the risk of glioma, but the results are controversial. Medline, PubMed, Embase, and Cochrane Library databases were independently searched by two investigators up to 13 July 2013. Summary odds ratios (OR) and 95 % confidence interval (CI) for Thr241Met polymorphism and prostate cancer were calculated. Statistical analysis was performed with the software program Stata 12.0. A total of 10 independent studies, including 4,136 cases and 5,233 controls, were identified. Our analysis suggested that Thr241Met was not associated with glioma risk in overall population. In the subgroup analysis, we detected no significant association between Thr241Met polymorphism and glioma risk in different descent populations. Subgroup analysis was held by source of controls, significant association was found between this polymorphism and glioma risk for population-based studies (homozygote model: OR = 1.747, 95 % CI = 1.123–2.717, P h = 0.059, I 2 = 59.7 %; recessive model, OR = 1.455, 95 % CI = 1.179–1.795, P h = 0.111, I 2 = 50.1 %; allele model, OR = 1.258, 95 % CI = 1.010–1.566, P h = 0.011, I 2 = 72.9 %). This meta-analysis showed the evidence that XRCC3 Thr241Met polymorphism was associated with a low risk of glioma development.

Keywords

Glioma XRCC3 Meta-analysis Polymorphism 

Notes

Conflicts of interest

The authors declare that they have no competing interests.

References

  1. 1.
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.PubMedCrossRefGoogle Scholar
  2. 2.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRefGoogle Scholar
  3. 3.
    Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93–108.PubMedCrossRefGoogle Scholar
  4. 4.
    Liu X, Li L, Chen X, et al. No association between EGF + 61 A/G polymorphism and increased risk of glioma. Int J Biol Markers. 2009;24:77–82.PubMedGoogle Scholar
  5. 5.
    De Roos AJ, Stewart PA, Linet MS, et al. Occupation and the risk of adult glioma in the United States. Cancer Causes Control. 2003;14:139–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Samkange-Zeeb F, Schlehofer B, Schuz J, et al. Occupation and risk of glioma, meningioma and acoustic neuroma: results from a German case–control study (interphone study group, Germany). Cancer Epidemiol. 2010;34:55–61.PubMedCrossRefGoogle Scholar
  7. 7.
    Maker HS, Syed H, Whetsell W, et al. Environmental factors modifying the effect of CCNU on glioma in vitro and in vivo. Trans Am Neurol Assoc. 1976;101:273–5.PubMedGoogle Scholar
  8. 8.
    Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, et al. Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst. 2001;93:1553–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Groothuis DR, Lippitz BE, Fekete I, et al. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma. Cancer Res. 1992;52:5590–6.PubMedGoogle Scholar
  10. 10.
    Bunin GR, Kuijten RR, Boesel CP, et al. Maternal diet and risk of astrocytic glioma in children: a report from the Childrens Cancer Group (United State and Canada). Cancer Causes Control. 1994;5:177–87.PubMedCrossRefGoogle Scholar
  11. 11.
    Chen H, Ward MH, Tucker KL, et al. Diet and risk of adult glioma in eastern Nebraska. United States Cancer Causes Control. 2002;13:647–55.CrossRefGoogle Scholar
  12. 12.
    Kabat GC, Park Y, Hollenbeck AR, et al. Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer. 2011;128:944–50.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Thompson LH, Schild D. Recombinational DNA repair and human disease. Mutat Res. 2002;509:49–78.PubMedCrossRefGoogle Scholar
  14. 14.
    Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair, and the cancer connection. Nat Genet. 2001;27:247–54.PubMedCrossRefGoogle Scholar
  15. 15.
    Bishop DK, Ear U, Bhattacharyya A, et al. XRCC3 is required for assembly of Rad51 complexes in vivo. J Biol Chem. 1998;273:21482–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Aka P, Mateuca R, Buchet JP, Thierens H, Kirsch-Volders M. Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutat Res. 2004;556:169–81.PubMedCrossRefGoogle Scholar
  17. 17.
    Angelini S, Kumar R, Carbone F, Maffei F, Forti GC, Violante FS, et al. Micronuclei in humans induced by exposure to low level of ionizing radiation: influence of polymorphisms in DNA repair genes. Mutat Res. 2005;570:105–17.PubMedCrossRefGoogle Scholar
  18. 18.
    Wang LE, Bondy ML, Shen HB, et al. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res. 2004;64:5560–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Kiuru A, Lindholm C, Heinavaara S, et al. XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol. 2008;88:135–42.PubMedCrossRefGoogle Scholar
  20. 20.
    Liu YH, Scheurer ME, El-Zein R, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Epidemiol Biomarkers Prev. 2009;18:204–14.CrossRefGoogle Scholar
  21. 21.
    Zhou KK, Liu Y, Zhang HS, et al. XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case–control study. Int J Cancer. 2009;124:2948–53.PubMedCrossRefGoogle Scholar
  22. 22.
    Rajaraman P, Hutchinson A, Wichner S, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol. 2010;12:37–48.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Liu HB, Peng YP, Dou CW, et al. Comprehensive study on associations between nine SNPs and glioma risk. Asian Pac J Cancer Prev. 2012;13:4905–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Custódio AC, Almeida LO, Pinto GR, et al. Variation in DNA repair gene XRCC3 affects susceptibility to astrocytomas and glioblastomas. Genet Mol Res. 2012;11:332–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Luo KQ, Mu SQ, Wu ZX, et al. Polymorphisms in DNA repair genes and risk of glioma and meningioma. Asian Pac J Cancer Prev. 2013;14:449–52.PubMedCrossRefGoogle Scholar
  26. 26.
    Pan WR, Li G, Guan JH. Polymorphisms in DNA repair genes and susceptibility to glioma in a Chinese population. Int J Mol Sci. 2013;14:3314–24.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Peng Zhao, Peng Zou, Lin Zhao, Wei Yan, Chunsheng Kang, Tao Jiang, Yongping You: genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility. BMC Cancer. 2013; 13:234.Google Scholar
  28. 28.
    Davey SG, Egger M. Meta-analyses of randomized controlled trials. Lancet. 1997;350:1182.Google Scholar
  29. 29.
    Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120–32.PubMedCrossRefGoogle Scholar
  30. 30.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Natl Cancer Inst. 1959;22:719–78.Google Scholar
  31. 31.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  32. 32.
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.PubMedCrossRefGoogle Scholar
  33. 33.
    Egger M, Smith DG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRefGoogle Scholar
  34. 34.
    Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-con-verting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia. 1998;41:47–53.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of NeurosurgeryGeneral Hospital of Shenyang Military RegionShenyangChina
  2. 2.Department of UltrasoundGeneral Hospital of Shenyang Military RegionShenyangChina

Personalised recommendations